These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2721269)

  • 1. Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients.
    Chelluri L; Warren J; Jastremski MS
    Chest; 1989 Jun; 95(6):1295-7. PubMed ID: 2721269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.
    Mann HJ; Fuhs DW; Awang R; Ndemo FA; Cerra FB
    Clin Pharm; 1987 Feb; 6(2):148-53. PubMed ID: 3665367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting aminoglycoside dosage in critically ill patients with sepsis.
    Stevens MR
    Clin Pharm; 1987 Apr; 6(4):272-3. PubMed ID: 3665382
    [No Abstract]   [Full Text] [Related]  

  • 5. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiency.
    Matzke GR; Millikin SP; Kovarik JM
    Clin Pharm; 1989 Nov; 8(11):800-6. PubMed ID: 2805631
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin volume of distribution in critically ill septic patients.
    Triginer C; Izquierdo I; Fernández R; Rello J; Torrent J; Benito S; Net A
    Intensive Care Med; 1990; 16(5):303-6. PubMed ID: 2212254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin and tobramycin in patients with various infections--concentrations in serum and urinary excretion.
    Kahlmeter G; Hallberg T; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():37-45. PubMed ID: 659348
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition.
    Ronchera-Oms CL; Tormo C; Ordovás JP; Abad J; Jiménez NV
    J Clin Pharm Ther; 1995 Oct; 20(5):253-8. PubMed ID: 8576291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal toxicity during therapy with gentamicin or tobramycin.
    Keys TF; Kurtz SB; Jones JD; Muller SM
    Mayo Clin Proc; 1981 Sep; 56(9):556-9. PubMed ID: 6115104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients.
    Reed RL; Wu AH; Miller-Crotchett P; Crotchett J; Fischer RP
    J Trauma; 1989 Nov; 29(11):1462-8; discussion 1468-70. PubMed ID: 2585556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms.
    Moellering RC; Wennersten C; Kunz LJ
    J Infect Dis; 1976 Aug; 134 Suppl():S40-9. PubMed ID: 972284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
    Etzel JV; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1992 Mar; 36(3):679-81. PubMed ID: 1622185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.
    Walker BD; Gentry LO
    J Infect Dis; 1976 Aug; 134 Suppl():S146-9. PubMed ID: 787449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.